Lowry Simon C
SEC CIK 2044279 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | SVP, CMO, R, D | 177.9K | — | — | 5 | 2024-12-15 | 2026-04-29 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 16:29 | 2026-04-29 | EBS | Emergent BioSolutions Inc. | Lowry Simon C | SVP, CMO, R, D | A - Grant | $0.00 | +100.1K | 177.9K | +129% | $0 | |
| D | 2026-03-05 | 2026-03-05 | EBS | Emergent BioSolutions Inc. | Lowry Simon C | SVP, CMO, R, D | F - Tax | $8.44 | -10.6K | 77.8K | -12% | -$89.8K |
| 2025-12-16 | 2025-12-14 | EBS | Emergent BioSolutions Inc. | Lowry Simon C | SVP, CMO, R, D | F - Tax | $11.41 | -3,543 | 88.4K | -4% | -$40.4K | |
| D | 2025-03-10 | 2025-03-06 | EBS | Emergent BioSolutions Inc. | Lowry Simon C | SVP, CMO, R, D | A - Grant | $0.00 | +62.5K | 92.0K | +212% | $0 |
| D | 2024-12-17 | 2024-12-15 | EBS | Emergent BioSolutions Inc. | Lowry Simon C | SVP, CMO, R, D | A - Grant | $0.00 | +29.5K | 29.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations